Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Key Takeaways From CROI 2018
Experts in the field of HIV provide their key takeaways from CROI 2018.
Rapid Entry Programs In South Prove Successful at Improving Access to HIV Care and Viral Suppression
Jonathan Colasanti, MD, MSPH, shares how the introduction of a Rapid Entry Program in Atlanta proved successful at improving access to HIV care and viral suppression rates.
<i>Pseudomonas</i> Infections: Matching Causes and Prevention
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Marin Hristos Kollef, MD; Andrew Shorr, MD; and Yoav Golan, MD, differentiate between pseudomonas colonization and infection, discussing important prevention methods regarding the causes of affliction.
Gram-Negative NIs: Vabomere and the TANGO II Study
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; and Andrew Shorr, MD, discuss the recent approval of Vabomere, a combination of meropenem and vaborbactam, in the setting of gram-negative nosocomial infections based on the positive study results of the TANGO II trial.
Diagnostic Tests for Gram-Negative Nosocomial Infections
Peter L. Salgo, MD; Debra Goff, PharmD, FCCP; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); Jason Pogue, PharmD, BCPS-AQID; and Andrew Shorr, MD, provide their perspectives on which tests are most important in identifying a gram-negative nosocomial infection and which approaches are necessary to optimize this stratification.
<i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?
Peter L. Salgo, MD; Marin Hristos Kollef, MD; Jason Pogue, PharmD, BCPS-AQID; Yoav Golan, MD; and Andrew Shorr, MD, identify which patients are most susceptible to Pseudomonas infections and address the settings in which risk for infection is greatest.
<i>C. difficile</i> Rates in the United Kingdom
Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.
Fecal Transplantation in <i>Clostridium difficile</i>
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, consider variables surrounding the use of fecal transplantation for the management of Clostridium difficile in select groups of patients.
FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.